SG Americas Securities LLC lifted its holdings in shares of Liquidia Corporation (NASDAQ: LQDA) by 46.7% during the undefined quarter, according to the company in its most recent filing with the SEC. The fund owned 54,696 shares of the company's stock after purchasing an additional 17,407 shares during the period. SG Americas Securities

Shares of Liquidia Corporation (NASDAQ: LQDA - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twelve brokerages that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, one has given a hold recommendation, seven have given a buy recommendation and two

Director Stephen Bloch sold 70,234 shares indirectly through Canaan VIII, L.P. in open-market transactions on March 26 and March 27, 2026.

The mean of analysts' price targets for Liquidia Corporation (LQDA) points to a 34.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Liquidia Corporation (NASDAQ: LQDA - Get Free Report) Director Stephen Bloch sold 62,550 shares of the stock in a transaction that occurred on Friday, March 27th. The stock was sold at an average price of $35.94, for a total transaction of $2,248,047.00. Following the completion of the transaction, the director owned 2,188,935 shares in the company,

Scott Moomaw sold 80,000 shares of common stock for a transaction value of approximately ~$2.83 million on March 9, 2026. The transaction represented 29.74% of his direct holdings, reducing direct ownership to 188,954 shares after the sale.

Liquidia Corporation (NASDAQ: LQDA - Get Free Report) insider Scott Moomaw sold 18,314 shares of the firm's stock in a transaction on Monday, March 23rd. The shares were sold at an average price of $36.79, for a total transaction of $673,772.06. Following the sale, the insider owned 187,640 shares in the company, valued at approximately $6,903,275.60.

The chief medical officer of Liquidia sold 35,365 common shares on March 13, 2026, for a transaction value of $1.28 million at around $36.30 per share. The sale was executed entirely from direct holdings; no indirect or derivative securities were involved.

Low-beta picks gain focus as Iran war fears stir volatility. AGRO, PRA, E and LQDA reflect resilience with momentum, liquidity and fundamentals.

Liquidia Corporation (LQDA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.